We are live on ! Find out more
STOK icon

Stoke Therapeutics
STOK

196 hedge funds and large institutions have $2.31B invested in Stoke Therapeutics in 2026 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 79 increasing their positions, 52 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

59% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 27

52% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 52

9% more capital invested

Capital invested by funds: $2.13B → $2.31B (+$189M)

7% more funds holding

Funds holding: 183 → 196 (+13)

2.94% more ownership

Funds ownership: 117.28% → 120.21% (+2.9%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

57% less call options, than puts

Call options by funds: $3.7M | Put options by funds: $8.68M

Holders
196
Holders Change
+13
Holders Change %
+7.1%
% of All Funds
2.41%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
43
Increased
79
Reduced
52
Closed
27
Calls
$3.7M
Puts
$8.68M
Net Calls
-$4.98M
Net Calls Change
-$22.7M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$77.4M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$51.2M
3
TCA
Troluce Capital Advisors
Puerto Rico
+$21.4M
4
Millennium Management
Millennium Management
New York
+$15.5M
5
Bank of America
Bank of America
North Carolina
+$11M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$38.8M
2
LCM
Lynx1 Capital Management
Puerto Rico
-$21M
3
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$10.5M
4
Goldman Sachs
Goldman Sachs
New York
-$10.2M
5
SL
Siren LLC
Connecticut
-$8.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
QC
126
Quadrature Capital
United Kingdom
$335K +$338K +10,293 New
VIA
127
Vanguard Investments Australia
Australia
$332K +$334K +10,186 New
VI
128
Vestcor Inc
New Brunswick, Canada
$331K – – –
Barclays
129
Barclays
United Kingdom
$329K -$4.62M -140,826 -93%
SEI Investments
130
SEI Investments
Pennsylvania
$325K -$218K -6,637 -40%
QCM
131
Quantinno Capital Management
New York
$318K -$43.1K -1,315 -12%
ProShare Advisors
132
ProShare Advisors
Maryland
$314K -$35K -1,067 -10%
Zurich Cantonal Bank
133
Zurich Cantonal Bank
Switzerland
$312K +$14.9K +453 +5%
Aviva
134
Aviva
United Kingdom
$302K -$216K -6,599 -42%
State Board of Administration of Florida Retirement System
135
State Board of Administration of Florida Retirement System
Florida
$296K +$298K +9,089 New
FCM
136
Farallon Capital Management
California
$293K – – –
KK
137
KLP Kapitalforvaltning
Norway
$287K +$19.7K +600 +7%
Acadian Asset Management
138
Acadian Asset Management
Massachusetts
$284K -$176K -5,375 -38%
TI
139
Tidal Investments
Wisconsin
$278K +$6.07K +185 +2%
TE
140
Tema ETFs
New York
$278K +$280K +8,540 New
VIA
141
Virtus Investment Advisers
Connecticut
$274K +$6.69K +204 +2%
VOYA Investment Management
142
VOYA Investment Management
Georgia
$267K +$14.6K +444 +6%
XT
143
XTX Topco
Cayman Islands
$262K +$264K +8,054 New
Prudential Financial
144
Prudential Financial
New Jersey
$249K +$251K +7,640 New
Pictet Asset Management
145
Pictet Asset Management
Switzerland
$247K +$249K +7,581 New
EFM
146
E Fund Management
China
$245K +$247K +7,530 New
SO
147
STRS Ohio
Ohio
$228K – – –
GIM
148
Generali Investments Management
Slovenia
$225K +$146K +4,441 +180%
SLAM
149
Swiss Life Asset Management
$213K -$8.33K -254 -4%
CIAM
150
Caitong International Asset Management
Hong Kong
$184K +$186K +5,662 New
4 5
6
7 8

STOK Hedge Fund Activity: Q1 2026 in Review

196 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in Stoke Therapeutics (STOK) for Q1 2026, worth a combined $2.31B — up 8.9% from $2.13B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new STOK positions and 27 closed out — a net gain of 16 holders — while 79 added to existing stakes and 52 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $77.4M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $38.8M sold.

  • 196 institutional investors held Stoke Therapeutics (STOK) as of Q1 2026, up from 183 in Q4 2025.
  • Funds reported $2.31B of Stoke Therapeutics stock for Q1 2026, up 8.9% quarter-over-quarter.
  • 43 funds opened new Stoke Therapeutics positions in Q1 2026 and 27 closed out, a net change of +16 holders.
  • The largest Stoke Therapeutics buyer in Q1 2026 was Wellington Management Group, an estimated $77.4M added.
  • The largest Stoke Therapeutics seller in Q1 2026 was Point72 Asset Management, an estimated $38.8M sold.

Based on aggregated 13F filings for Q1 2026.